A consolidated list of all the FDA approved medications during the month of January 2026.
- Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution)
- For the treatment of presbyopia in adults.
- Darzalex Faspro (daratumumab and hyaluronidase-fihj) New Indication
- In combination with bortezomib, lenalidomide and dexamethasone (D-VRd) for the treatment of adult patients with newly diagnosed multiple myeloma (NDMM) who are ineligible for autologous stem cell transplant (ASCT). D-VRd is the only anti-CD38 antibody-based regimen with approved indications across newly diagnosed patients, regardless of transplant eligibility.
- Nexplanon (etonogestrel implant) Expanded Indication
- For use by women of reproductive potential to prevent pregnancy for up to five years (expanded from 3 years).
- Filkri (filgrastim-laha) Biosimilar to Neupogen
- Multiple indications as a biosimilar to Neupogen.
- Zycubo (copper histidinate)
- For the treatment of Menkes disease.
Make sure to sign up for alerts and stay informed on all the latest published guidelines, FDA decisions, and more!
Copyright © 2026 Guideline Central, All Rights Reserved.